Showing 261 - 280 results of 1,553 for search '"erectile dysfunction"', query time: 0.11s Refine Results
  1. 261
  2. 262
  3. 263
  4. 264
  5. 265
  6. 266
  7. 267
  8. 268

    P2.08 INTERRELATIONSHIPS BETWEEN METABOLIC SYNDROME, ERECTILE DYSFUNCTION AND EARLY ATHEROSCLEROSIS by N. Ioakeimidis, C. Vlachopoulos, G. Antoniou, K. Baou, D. Terentes-Printzios, A. Aggelis, I. Dima, P. Xaplanteris, G. Lazaros, C. Stefanadis

    Published 2009-12-01
    “…Purpose: Men with metabolic syndrome (MetS) have an increased prevalence of erectile dysfunction (ED). Large artery stiffness is a marker of vascular wall changes associated with MetS. …”
    Get full text
    Article
  9. 269

    Phosphodiesterase type 5 inhibitor (Levitra): possibility of correction of erectile dysfunction in obese patients

    Published 2008-03-01
    “…Despite the fact that in the literature there are few publications on the relationship of obesity and erectile dysfunction (ED), we could not find work on the effectiveness of treatment of patients with erectile dysfunction and obesity. …”
    Get full text
    Article
  10. 270
  11. 271
  12. 272
  13. 273
  14. 274
  15. 275
  16. 276
  17. 277
  18. 278

    Association Between Prostate Zonal Volume and Erectile Dysfunction in Patients With Benign Prostatic Hyperplasia by Muhammed M. Qalawena, MD, Mohammad A. Al-Shatouri, MD, Mokhtar A. Motawaa, MD, Ahmed I. El-Sakka, MD

    Published 2020-06-01
    “…Aim: To assess the association between prostate zonal volume and erectile dysfunction in patients with benign prostatic hyperplasia. …”
    Get full text
    Article
  19. 279

    Association between diabetes mellitus and corpus cavernosum arterial insufficiency in patients with erectile dysfunction by Palmer José Hernández-Yépez, Fiorella Inga-Berrospi, Carlos Muñoz Medina, Vanessa Velezmoro Diaz, José Antonio Grandez-Urbina

    Published 2023-05-01
    “…Introduction: Erectile dysfunction is highly prevalent in the population and vascular and neural processes are involved in its pathophysiology, including those related to late complications of diabetes mellitus. …”
    Get full text
    Article
  20. 280

    PHARMACOTHERAPY IN PATIENTS WITH ERECTILE DYSFUNCTION AND BENIGN PROSTATIC HYPERPLASIA IN THE ABSENCE OF RISK OF DISEASE PROGRESSION by A. A. Kamalov, A. M. Tahirzade

    Published 2018-03-01
    “…Evaluation of the effectiveness and safety of various pharmacotherapy options in patients with erectile dysfunction (ED) in combination with benign prostatic hyperplasia (BPH).Materials and methods. …”
    Get full text
    Article